Ledger.Open graph →

SEC Form D · Amendment · filed December 2, 2024

Gemelli Biotech Corp

Offering

$23.9M

Sold

$21.2M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Raleigh, NC

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

James A. Laur · Raleigh, NCExec · Director John A. Neczesny · Raleigh, NCDirector Matthew Mitcho · Raleigh, NCExec · Director Oded A. Levy · Raleigh, NCDirector Ritish A. Agarwal · Raleigh, NCDirector James Laur · Raleigh, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗